[RDN对耐心高血压患者与不同心血管风险分层的长期血压的影响]
1Department of Cardiology, Tianjin First Central Hospital, Tianjin 300192, China.
Zhonghua xin xue guan bing za zhi
|August 15, 2024
概括
脏缺血 (RDN) 为高血压患者提供长期的血压控制和安全. 高风险个人可能会从RDN中获得更大的好处,在这个真实世界的研究中显示出更好的结果.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 干预心脏病学 干预心脏病学
背景情况:
- 耐药性高血压带来了相当大的心血管风险.
- 脏缺血 (RDN) 是一种新兴的治疗方法,用于治疗抗性高血压.
- 关于RDN在不同心血管风险层中的有效性和安全性的长期数据有限.
研究的目的:
- 评估RDN在高血压患者的长期治疗效果和安全性.
- 根据基线心血管风险分层的患者的RDN结局进行比较.
- 评估RDN对11年的不良事件和死亡率的影响.
主要方法:
- 一个单中心,单臂,现实世界的回顾性研究,对62名耐火性高血压患者进行.
- 患者被分为高风险和中低风险组.
- 血压,功能,药物使用和死亡率在RDN后长达11年被监测.
主要成果:
- 高风险患者在11年内,与中低风险患者相比,缩血压显著降低.
- 两组之间没有观察到心率,抗高血压药物使用或功能 (肌素,EGFR) 的显著差异.
- 风险组之间的累积心血管和全因死亡率没有显著差异,11年后的总比率分别为8.1%和11.3%.
结论:
- 脏皮表现出持续的抗高血压作用和有利的长期安全性.
- 高风险高血压患者可以通过RDN获得优异的血压降低.
- 对于一些耐性高血压患者来说,RDN是一种安全有效的治疗选择.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
405
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
405
Antihypertensive Drugs: Direct Renin Inhibitors
513
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
513
Hypertension and Regulation of Blood Pressure
2.0K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.0K
Heart Failure Drugs: Diuretics
352
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
352
Factors affecting Blood pressure
3.1K
Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Physiological Factors:
3.1K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
541
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
541


